Загрузка...
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
Mevalonate kinase deficiency (MKD) is a severe autoinflammatory disease caused by recessive mutations in MVK resulting in reduced function of the enzyme mevalonate kinase, involved in the cholesterol/isoprenoid pathway. MKD presents with periodic episodes of severe systemic inflammation, poor qualit...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Limited
2018-01-01
|
| Серии: | Case Reports in Pediatrics |
| Online-ссылка: | http://dx.doi.org/10.1155/2018/3514645 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|